Growth Metrics

Bruker (BRKR) Current Deferred Revenue (2016 - 2025)

Bruker (BRKR) has disclosed Current Deferred Revenue for 16 consecutive years, with $441.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 18.0% year-over-year to $441.3 million, compared with a TTM value of $441.3 million through Dec 2025, down 18.0%, and an annual FY2025 reading of $441.3 million, down 18.0% over the prior year.
  • Current Deferred Revenue was $441.3 million for Q4 2025 at Bruker, down from $562.2 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $584.1 million in Q2 2025 and bottomed at $196.7 million in Q2 2022.
  • Average Current Deferred Revenue over 5 years is $428.2 million, with a median of $411.8 million recorded in 2021.
  • The sharpest move saw Current Deferred Revenue surged 176.98% in 2021, then plummeted 52.63% in 2022.
  • Year by year, Current Deferred Revenue stood at $430.8 million in 2021, then dropped by 14.07% to $370.2 million in 2022, then increased by 8.05% to $400.0 million in 2023, then surged by 34.55% to $538.2 million in 2024, then decreased by 18.0% to $441.3 million in 2025.
  • Business Quant data shows Current Deferred Revenue for BRKR at $441.3 million in Q4 2025, $562.2 million in Q3 2025, and $584.1 million in Q2 2025.